Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Liver Neoplasms × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Liver Neoplasms 1 Carcinoma, Medullary 1 Adenoma, Islet Cell 1 Adenocarcinoma, Follicular 1

Interventions

sodium thiosulfate 1 cabozantinib 1 Ramucirumab 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01908426 2021-05-06

CELESTIAL

Exelixis

Phase 3 Completed

707 enrolled 20 charts 1 FDA

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡